Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$176.16
-0.6%
$174.52
$163.33
$251.99
$50.81B0.252.06 million shs1.06 million shs
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$164.80
+1.7%
$155.04
$93.17
$168.44
$38.66B0.682.25 million shs1.23 million shs
Straumann Holding AG stock logo
SAUHY
Straumann
$13.35
-0.9%
$12.93
$10.30
$16.90
$21.48B1.5564,438 shs27,727 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$221.75
+0.2%
$215.69
$187.43
$352.33
$15.89B1.09735,377 shs370,766 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.27%+3.51%+4.60%-20.10%-22.75%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
-1.35%-1.15%+4.31%+18.19%+67.68%
Straumann Holding AG stock logo
SAUHY
Straumann
+1.97%+5.48%+4.99%+17.95%+7.07%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-0.49%+0.10%+5.69%+0.69%-31.39%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.8094 of 5 stars
3.23.03.34.02.92.51.3
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.8192 of 5 stars
2.44.04.23.63.51.71.9
Straumann Holding AG stock logo
SAUHY
Straumann
N/AN/AN/AN/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.7645 of 5 stars
3.44.01.73.22.41.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.36
Hold$219.2224.44% Upside
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.79
Moderate Buy$157.43-4.47% Downside
Straumann Holding AG stock logo
SAUHY
Straumann
4.00
Strong BuyN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.89
Moderate Buy$320.0044.31% Upside

Current Analyst Ratings Breakdown

Latest SAUHY, BDX, CAH, and WST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$245.00
6/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$166.00 ➝ $181.00
6/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$157.00 ➝ $170.00
6/12/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00 ➝ $180.00
6/10/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$165.00 ➝ $170.00
6/3/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$261.00 ➝ $241.00
6/3/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$136.00 ➝ $179.00
5/22/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/22/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold$217.00 ➝ $185.00
5/6/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$280.00 ➝ $196.00
5/5/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$142.00 ➝ $166.00
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.18B2.50$21.00 per share8.39$89.57 per share1.97
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$226.83B0.17$10.71 per share15.38($13.19) per share-12.49
Straumann Holding AG stock logo
SAUHY
Straumann
$2.84B7.48$0.46 per share29.23$1.46 per share9.14
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B5.51$9.03 per share24.55$37.04 per share5.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$5.2433.6211.261.347.28%15.99%7.36%8/7/2025 (Estimated)
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$852M$6.4125.7118.411.600.70%-68.84%4.21%8/13/2025 (Estimated)
Straumann Holding AG stock logo
SAUHY
Straumann
$441.09MN/A0.0029.672.23N/AN/AN/A8/13/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.3734.8128.215.4416.13%18.23%13.51%7/24/2025 (Estimated)

Latest SAUHY, BDX, CAH, and WST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51N/AN/AN/A$725.11 millionN/A
5/1/2025Q2 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.28$3.35+$0.07$1.06$5.35 billion$5.27 billion
5/1/2025Q3 2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.15$2.35+$0.20$2.10$55.33 billion$54.88 billion
4/24/2025Q1 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.22$1.45+$0.23$1.23$685.24 million$698.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.162.36%N/A79.39%53 Years
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.041.24%N/A31.83%29 Years
Straumann Holding AG stock logo
SAUHY
Straumann
$0.030.22%N/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.38%N/A13.19%N/A

Latest SAUHY, BDX, CAH, and WST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.39%7/30/20257/30/20258/6/2025
5/5/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.51071.35%7/1/20257/1/20257/15/2025
4/29/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.042.02%6/9/20256/9/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.70
1.13
0.64
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.94
0.50
Straumann Holding AG stock logo
SAUHY
Straumann
N/A
1.61
1.15
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.08
2.77
2.03

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Straumann Holding AG stock logo
SAUHY
Straumann
N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000286.61 million285.58 millionOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,900238.68 million238.46 millionOptionable
Straumann Holding AG stock logo
SAUHY
Straumann
11,8151.59 billionN/ANot Optionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.85 million71.46 millionOptionable

Recent News About These Companies

Investors in West Pharmaceutical Services, Inc. ...
West Pharmaceutical Services (WST) Fell on Lowered Guidance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$176.16 -1.11 (-0.63%)
Closing price 03:30 PM Eastern
Extended Trading
$176.34 +0.18 (+0.10%)
As of 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Cardinal Health stock logo

Cardinal Health NYSE:CAH

$164.80 +2.82 (+1.74%)
Closing price 03:41 PM Eastern
Extended Trading
$164.80 0.00 (0.00%)
As of 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Straumann stock logo

Straumann OTCMKTS:SAUHY

$13.35 -0.12 (-0.89%)
As of 12:53 PM Eastern

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$221.75 +0.53 (+0.24%)
Closing price 03:30 PM Eastern
Extended Trading
$221.74 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.